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ABSTRACT
The 1918-1919 influenza pandemic remains the single greatest infectious disease outbreak in the past century. Mouse and non-
human primate infectionmodels have shown that the 1918 virus induces overly aggressive innate and proinflammatory re-
sponses. To understand the response to viral infection and the role of individual 1918 genes on the host response to the 1918 vi-
rus, we examined reassortant avian viruses nearly identical to the pandemic 1918 virus (1918-like avian virus) carrying either the
1918 hemagglutinin (HA) or PB2 gene. In mice, both genes enhanced 1918-like avian virus replication, but only the mammalian
host adaptation of the 1918-like avian virus through reassortment of the 1918 PB2 led to increased lethality. Through the combi-
nation of viral genetics and host transcriptional profiling, we provide a multidimensional view of the molecular mechanisms by
which the 1918 PB2 gene drives viral pathogenicity. We demonstrate that 1918 PB2 enhances immune and inflammatory re-
sponses concomitant with increased cellular infiltration in the lung. We also show for the first time, that 1918 PB2 expression
results in the repression of both canonical and noncanonical Wnt signaling pathways, which are crucial for inflammation-medi-
ated lung regeneration and repair. Finally, we utilize regulatory enrichment and network analysis to define the molecular regula-
tors of inflammation, epithelial regeneration, and lung immunopathology that are dysregulated during influenza virus infection.
Taken together, our data suggest that while both HA and PB2 are important for viral replication, only 1918 PB2 exacerbates lung
damage in mice infected with a reassortant 1918-like avian virus.
IMPORTANCE
As viral pathogenesis is determined in part by the host response, understanding the key host molecular driver(s) of virus-medi-
ated disease, in relation to individual viral genes, is a promising approach to host-oriented drug efforts in preventing disease.
Previous studies have demonstrated the importance of host adaptive genes, HA and PB2, in mediating disease although the
mechanisms by which they do so are still poorly understood. Here, we combine viral genetics and host transcriptional profiling
to show that although both 1918 HA and 1918 PB2 are important mediators of efficient viral replication, only 1918 PB2 impacts
the pathogenicity of an avian influenza virus sharing high homology to the 1918 pandemic influenza virus. We demonstrate that
1918 PB2 enhances deleterious inflammatory responses and the inhibition of regeneration and repair functions coordinated by
Wnt signaling in the lungs of infected mice, thereby promoting virus-associated disease.
Annual influenza epidemics cause significant morbidity andmortality. On occasion, novel influenza A strains emerge that
are capable of producing severe respiratory disease on a global
scale (1). The 1918-1919 pandemic was an unprecedented event,
with an estimated 40 to 50 million deaths worldwide (2, 3). Se-
quence analysis indicates that the 1918 pandemic influenza virus
is avian in origin (4–8) and 1918 viral genes are highly homolo-
gous to those of circulating avian influenza H1N1 viruses (9). In a
recent study, a reconstructed virus comprised of avian influenza
viral segments with high homology to the 1918 virus was shown to
be pathogenic in ferrets and mice. Specific amino acid changes in
PB2 and PA viral polymerase proteins, in combination with
amino acid changes in the hemagglutinin (HA) viral glycoprotein,
resulted in the “1918-like avian virus” efficiently transmitting be-
tween ferrets via the respiratory droplet route (9). Host-adaptive
changes in polymerase and NP genes enhancing avian influenza
virus replicative fitness are well documented (10, 11). In particu-
lar, PB2 627K has become a genomic signature of host adaptation,
whichwas present in the 1918 pandemic influenza virus PB2 gene,
though novel host adaptive mutations continue to be character-
ized in the ribonucleoprotein complex (12–14). These human-
adaptive changes may confer efficient replication of avian influ-
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enza viruses in humans raising concerns about the pandemic
potential of circulating avian influenza viruses. Influenza virus
genes involved in host adaptation are key virulence determinants,
although the importance of these genes in the context of a virus
sharing close homology to 1918 is still unknown.
Two of the most well-characterized viral determinants of 1918
pathogenesis are HA and neuraminidase (NA) (15–17). In the
genetic background of a human H1N1 influenza virus, 1918 HA
and NA induced macrophages and neutrophils into the lung that
play an important role in the control of virus replication (18, 19).
The HA glycoprotein is required for influenza virus binding to
sialic acid receptors on the host cell surface, whereas NA cata-
lyzes these linkages to promote egress of progeny virions. The
HA receptor-binding site is invariant in all avian HAs [with a
preferential binding for (2-3) sialic acids]; however, it varies
in mammalian-adapted HA that exhibit preferential binding to
(2-6)-linked sialic acids (20–22). Genomic-based approaches
have expanded on our understanding of HA-mediated virulence
by demonstrating that, aside from the role HA plays in dictating
viral tropism, HA promotes protracted proinflammatory re-
sponses involving acute phase signaling and protein ubiquitina-
tion pathways (17, 18).
In contrast to 1918, exchange ofH5N1HAandNAgenes in the
genetic background of a nonlethal avian virus did not increase
pathogenicity but rather the substitution of the polymerase genes
contribute to H5N1 pathogenesis (23–25). The PB2 gene, which
encodes one of the three viral RNA polymerase subunits required
for viral replication (26), is also a determinant of host range and
virulence of avian influenza viruses (12, 27, 28). Characterization
of the adaptationmarkers of PB2 has demonstrated crucial amino
acid substitutions in the PB2, including E627K, protein of avian
influenza viruses (29, 30), which play an important role in en-
hancing replication of avian viruses in mammalian cells and
mouse lungs. On the other hand, insertion of PB2 from a low-
pathogenicity avian influenza H1N1 virus into the genetic back-
ground of 1918 diminishes virulence inmice (31).While adaptive
changes in HA have been described as a major virulence determi-
nant and contributes to unabated proinflammatory responses
elicited by the 1918 virus (18, 32), howPB2 contributes to changes
in the host response remains to be addressed.
Here, we evaluate the global transcriptional responses to influ-
enza viruses sharing close homology to the 1918 virus to evaluate
the biological processes that drive disease severity. We use single-
reassortant viruses in the backbone of the “1918-like avian virus”
and apply genomic-based approaches to understand the impact of
1918 HA and 1918 PB2 on host transcriptional responses to influ-
enza A virus (IAV) infection. We demonstrate that the 1918 PB2
gene enhances both the kinetics and the magnitude of the host
response to viral infection, leading to the induction of strong in-
flammatory responses with increased cellular infiltration in the
infected lung. Finally, we show that expression of 1918 PB2 results
in the repression of Wnt signaling exacerbating inflammatory re-
sponses and impairing lung regenerative and repair functions.
MATERIALS AND METHODS
Cells and viruses. Human embryonic kidney (HEK293T) cells and Ma-
din-Darby canine kidney (MDCK) cells were cultured in Dulbecco mod-
ified Eagle medium (DMEM) supplemented with 10% fetal calf serum
and minimal essential medium supplemented with 5% newborn calf se-
rum, respectively. A549 cells and derived cell lines were cultured in
DMEM supplemented with 10% fetal bovine serum and 1% penicillin-
streptomycin. All cells were maintained at 37°C in 5% CO2. With the
exception of A/duck/Alberta/35/76 (DK/ALB), all viruses used in this
study were generated by plasmid-driven reverse genetics and propagated
as previously described (9, 33).
Mouse experiments. Five- to six-week-old female BALB/cmice (Jack-
son Laboratory) were used for the experiments. Isoflurane-anesthetized
mice were intranasally inoculated with 10-fold serial dilutions of 1918,
1918-like avian, 1918 PB2/avian, and 1918 HA/avian viruses. The dose
required to kill 50% of mice (MLD50) was calculated using the Reed-
Muench method (34). For analysis of virus growth and microarray pro-
filing, mice were intranasally inoculated with 106 PFU of virus (n 4/vi-
rus/time point) or PBS (n  3/time point). At days 1, 2, and 4 after
infection, lungs were harvested from the infected mice. Lungs were pro-
cessed for RNA extraction for microarray studies and virus titer determi-
nation. Statistical analyses for virus lung titers were performed by using
analysis of variance (ANOVA) in GraphPad Prism version 5.0 (GraphPad
Software, Inc., La Jolla, CA); P values of 0.05 were considered signifi-
cant.
All experiments with the 1918-like viruses were performed in a bio-
safety level 3 containment laboratory approved for suchuse by theCenters
for Disease Control and Prevention (CDC) and the U.S. Department of
Agriculture. The research program, procedures, occupational health plan,
documentation, security, and facilities are reviewed annually by the Uni-
versity of Wisconsin—Madison Responsible Official and at regular inter-
vals by the CDC and the Animal and Plant Health Inspection Service as
part of the University of Wisconsin—Madison Select Agent Program. All
animal experiments were performed in accordance with the University of
Wisconsin—Madison’s Regulations for Animal Care and Use and ap-
proved by the Animal Experiment Committee of the University of Wis-
consin—Madison.
Mouse microarray experiments and data processing. RNA was iso-
lated from total lung homogenates, and fluorescently labeled probes were
generated from each sample using Agilent One-Color LowInput Quick
Amp labeling kit (Agilent Technologies). Individual cRNA samples were
hybridized to oligonucleotide microarrays for gene expression profiling
using a whole-mouse genome microarray kit (G4122A; Agilent Technol-
ogies), as previously described (17). RNA isolated from control animal
lungs served as an uninfected reference. Quantitative reverse transcrip-
tion-PCRwas performedonmouse lung samples using a primer-probe set
targeting the viral matrix sequence and confirmed all infected samples
expressed matrix mRNA.
The primary transcriptomic data were extracted and quantile normal-
ized using the “normalizeBetweenArrays” method available in the
“limma” package of the R suite as previously described (35) and adjusted
for batch effects using the ComBat software (36). Expressions across each
sample were then normalized to the average expression of study and time-
matched mocks. Differential expression of 1918 wild-type (WT) and
1918-like avian reassortant viruses was determined by comparing the av-
erage gene expression of influenza virus-infected replicates to the average
of time-matchedmock-infected samples applying a linear model fit using
the “limma” package. Criteria for differential expression were an absolute
log2-fold change of 3 and an adjusted P value of 0.05, calculated by
Benjamini-Hochberg correction (1).
Functional enrichment analysis. Functional analysis of differentially
expressed (DE) genes was done using Ingenuity Pathway Analysis (IPA;
Ingenuity Systems). IPA function enrichment was calculated using a
right-tailed Fisher exact test with a threshold of significance set at P value
of 0.05. Enrichment of diseases and biological functions and upstream
regulators were based on activation |z-scores| 2. Analysis of upstream
regulators was performed using the web-based software tool, Enrichr
(37), which utilizes the ChIP-x Enrichment Analysis (ChEA) database
(38) of experimentally validated putative targets for transcription factors
in mammalian cells. Regulatory transcription factors were ranked based
on the combined score Combined scores are derived by multiplying the P
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value determined by the Fisher exact test, and the computed z-score to
assess the deviation from the expected rank. The Wikipathways and
KEGG tools in Enrichr were also used for functional analysis.
Computational measurement of immune cell subsets. To predict
immune cell composition, we utilized microarray data available from
Mouse GeneAtlas v3 (GEO accession number GSE10246) as previously
described (35). A Fisher exact test was used to determine enrichment
scores for each module relative to the expression of DE genes in our data
set enrichment scores (ES) were reported as log10 (P value), and the
cutoff for significant enrichment was set at ES 1.3. Specific immune cell
dynamics where probed using the digital cell quantifier (DCQ) algorithm.
Briefly, genome-wide gene expression for each infectious condition was
normalized relative to the average of the time-matched mock and log2
transformation was applied. The data were transformed by dividing each
gene expression entry by the standard deviation across test samples. Anal-
ysis of relative cell quantity was run with three repeats and a lambda
minimum of 0.2 as previously described (39).
Luciferase reporter assay. An A549-derived -catenin reporter cell
line was generated (A549-BAR), as previously described (40, 41). A549-
BAR cells were transfected with 4 g of plasmids expressing YFP, 1918
PB2, or avian PB2 using X-tremegene HP (Roche), followed by stimula-
tion with 50 ng of recombinant Wnt3A (Peprotech)/ml for the indicated
time points. Firefly and Renilla luciferase activity was assessed using the
Dual-Glo luciferase assay system (Promega). Firefly luciferase activity was
normalized to Renilla luciferase activity and expressed as fold changes
relative to mock-treated cells.
Quantitative PCR of gene expression. Total RNA from A549 BAR
cells was extracted using Qiazol reagent (Qiagen). The RNA was DNase
treated and reverse transcribed using a QuantiTect reverse transcription
kit (Qiagen). Real-time PCR was performed on the synthesized DNA
using the SYBR Select master mix (Invitrogen) and a 7900HT real-time
system (Applied Biosciences) according to the manufacturer’s instruc-
tions. Primers sequences used for target gene amplification are available
upon request. Samples were normalized to GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) and expressed as the fold change with respect
to mock-treated vector control cells. Statistical analyses for gene expres-
sion were performed by using ANOVA with a Bonferroni correction in
GraphPad Prism version 5.0; P values of 0.05 were considered signifi-
cant.
Data dissemination. The data used in this study are available via the
following accession identifiers on the NCBI-GEO database: A/duck/Al-
berta/35/76 (DUCK), A/Brevig Mission/1/18 (1918WT), 1918-like avian
virus, 1918 HA/avian, and 1918 PB2/avian viruses with the associated
mock-infected conditions (GSE70502); 1918 WT, 1918HA/K173,
1918PB1/K173, and 1918(3P	NP)/K173 viruses (GSE44595); andA/Cal-
ifornia/04/2009, mouse-adapted A/California/04/2009, A/New Jersey/8/
76, A/Brisbane/59/2007, A/Mexico/4482/2009, and 1918 WT viruses
(GSE36328).
RESULTS
The 1918 PB2 andHAgenes enhance the replicative potential of
a 1918-like avian virus. In previous studies, a reconstructed 1918-
like avian virus containing viral segments that share close homol-
ogy to the 1918 virus was moderately pathogenic (i.e., a mouse
50% lethal dose [MLD50] of 5.5 log10 PFU) in mice compared to
an authentic, low-pathogenicity avian influenza virus (A/duck/
ALB/35/76; DK/ALB) (MLD50 of 6.8 log10 PFU) and the highly
pathogenic 1918 pandemic virus (MLD50 of 2.7 log10 PFU) (9). To
understand the impact of theHA andPB2 genes, which contribute
to the host range, pathogenicity, and replication of the 1918 and
H5N1 viruses (12, 23, 27, 42) on the virulence of the 1918-like
avian virus, we constructed single-gene reassortant viruses com-
posed of either the 1918 HA or PB2 gene in the genetic back-
ground of the 1918-like avian virus (Fig. 1A). Introduction of the
FIG 1 Pathogenicity of the 1918 and 1918-like reassortant viruses. The
biological properties of the 1918WT, 1918-like avian, 1918 PB2/avian, and
1918 HA/avian viruses were determined. (A) Schematic of 1918 viral gene
reassortants. (B) Calculation of median lethal dose (MLD50) of 1918 PB2
and 1918 HA reassortant viruses. MLD50 values for 1918 WT and the 1918-
like avian viruses were previously calculated and reported by Watanabe et
al. (9). (C) Lung titers of C57/Bl6 mice intranasally inoculated with 104
PFU of virus. Viral titers were determined by plaque assay in MDCK cells.
Represented are the mean lung titers (n  4/virus) and their standard
deviations. Asterisks indicate statistical significance: ***, P 0.001; **, P
0.01; and *, P  0.05.
Forero et al.
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1918 PB2 gene (1918 PB2/avian) into the 1918-like avian virus
backbone decreased theMLD50 (MLD50 of 1.3 log10 PFU). On the
other hand, introduction of the 1918 HA gene (1918 HA/avian)
into the avian backbone had no impact on pathogenicity (MLD50
of 5.5 log10 PFU) (Fig. 1B). These results suggest that in themouse,
mammalian adaptation conferred by 1918 PB2, but not HA, pro-
motes pathogenesis of a virus closely resembling the 1918 pan-
demic strain.
We then evaluated the viral growth kinetics in the lung after
intranasal inoculation of mice with 1918 WT, 1918-like avian,
1918 PB2/avian, 1918 HA/avian, or DK/ALB (n  4/virus; 106
PFU). Lung titers of 1918 WT, 1918-like avian, 1918 PB2/avian,
and 1918HA/avian viruses were significantly greater than those of
the nonpathogenic avian strain, DK/ALB, at all time points. The
growth of the 1918-like avian virus was three orders of magnitude
lower than that of the 1918 WT virus (Fig. 1C). We observed a
10-fold increase in the lung viral titers after insertion of the 1918
HA into the avian backbone. Similarly, 1918 PB2 had a robust
impact on viral replication as we observed viral growth compara-
ble to that of the 1918 WT virus. Moreover, 3 of 4 mice infected
with 1918 PB2/avian succumbed to viral infection by day 4 postin-
fection (p.i.), while all other mice survived viral challenge. Fur-
thermore,mammalian adaptation of the 1918-like avian PB2 gene
through substitution of 627 glutamic acid residue to lysine was
sufficient to enhance the polymerase activity of the 1918-like avian
virus polymerase complex in human epithelial cell lines (9) and
increased viral virulence in infected mice (MLD50 of 1.4 log10
PFU). These results suggest that both the 1918 PB2 and the HA
genes enhance the replicative potential of the 1918-like avian vi-
rus, but only the 1918 PB2 promotes viral pathogenicity in the
backbone of an avian virus sharing high homology to 1918. Given
the similarity in the viral replication of 1918 PB2/avian and 1918
WT, the enhanced lethality observed in 1918 PB2/avian-infected
mice is likely independent of viral replication and suggests that the
virus-host interactions that shape the host response are a major
factor of viral pathogenicity.
1918 PB2 enhances the kinetics and magnitude of the early
host response to the 1918-like avian virus. To evaluate distinc-
tions in the host responses elicited by the 1918 WT and the 1918-
like avian viruses, we profiled the global lung transcriptional
changes in mice infected with viruses of high (1918 WT and 1918
PB2/avian), intermediate (1918-like avian and 1918HA/avian),
and low (DK/ALB) pathogenicity. These profiles were visual-
ized by multidimensional scaling (MDS) and a high degree of
similarity between the 1918 WT, 1918-like avian, and 1918
HA/avian viruses at day 1 p.i. was revealed. On the other hand,
the transcriptional signature of 1918 PB2/avian diverged from
all other infection conditions beginning at day 1. However, at
days 2 and 4 p.i., gene expression profiles induced by the highly
pathogenic viruses were closely related and diverged from the
profiles induced by viruses with intermediate pathogenicity
(Fig. 2A).
We detected robust changes in transcriptional responses
early after infection with highly or intermediately pathogenic
viruses (log fold change |3|). The modest detectable changes
in differentially expressed (DE) genes, and their decrease to
baseline in DK/ALB-infected mice, were suggestive of the con-
trol and resolution of viral infection. Expression of 1918 PB2
had a stark impact on host gene expression during later time
points given that we detected a3-fold increase in the number
of DE genes at the later time points of infection (Fig. 2B). By
determining the intersection among DE genes for each condi-
tion at each time point (Fig. 2D to F), we noted a high degree of
overlap in the gene expression promoted by 1918 PB2 expres-
sion at days 2 and 4 p.i. (Fig. 2E and F), supporting the obser-
vations made through the MDS analysis.
To further probe the consequences of 1918 PB2 on lung gene
expression and the molecular pathways associated with enhanced
viral pathogenesis, we clustered the 4,013 DE genes according to
their expression pattern (Fig. 2C) and performed canonical path-
way enrichment analysis on gene sets corresponding to each clus-
ter (Table 1). Overall, the magnitude of gene expression was
greater in response to viruses expressing the 1918 PB2 genes (1918
WT and 1918 PB2/avian) during the course of infection. In all
infection conditions, we observed the upregulation of pattern rec-
ognition receptor-mediated antiviral responses and inflammatory
responses (cluster 5). There was sustained expression of genes
involved in antiviral and inflammatory responses (clusters 1, 4,
and 5), and the late induction of DNA damage and cell cycle reg-
ulatory genes (cluster 3), as well as genes involved in wound heal-
ing (cluster 2), that was concomitant with increased virulence of
the 1918 and the 1918-like viruses. Taken together, these data
demonstrate that mammalian adaptation of PB2, rather than HA,
affects both the kinetics and the magnitude of host gene expres-
sion culminating in the enhancement of the pathogenesis of a
1918-like avian virus.
1918 PB2 is a key driver of inflammatory responses enhanc-
ing immune cell infiltration and activation in the infected lung.
Previously, we reported that the early inflammatory response to
IAV infection can severely impact the disease outcome (35). To
better understand whether 1918 PB2 contributes to these detri-
mental responses, we focused on genes upregulated immediately
following IAV infection at day 1 p.i. and whose expression was
sustained throughout infection only in 1918 WT and 1918 PB2/
avian infected mice (Fig. 2C; cluster 4, “black”). These genes were
specifically involved in innate responses, the communication be-
tween innate and adaptive immune cells (P 1.57E–6), and gran-
ulocyte/agranulocyte adhesion and diapedesis (Table 1). We inte-
grated our early response profiles (day 1 p.i.) with those from
previous studies of H1N1 infection to determine whether 1918
PB2 expression led to increased gene expression (17, 35). Approx-
imately 20% of cluster 4 genes were significantly altered by 1918
PB2, including cytokines and chemokine genes and their recep-
tors, such as Csf3, Il1b, Cxcl2, and Cxcr2, as well as the cytokine
regulatory gene, Socs3 (Fig. 3A). We next evaluated potential reg-
ulators mediating the cluster 4 gene expression by utilizing ChIP
enrichment analysis (ChEA). We identified Stat3, a crucial regu-
lator of interleukin-6 (IL-6)-mediated inflammation and lung re-
pair (43), as an upstream regulator of the response to 1918 WT
and 1918-like avian viruses (Fig. 3B). Additionally, regulators
of lymphocyte development (Lmo2, Runx1, and Gata2), differ-
entiation (Stat4 and Stat5), or immune cell-specific activation
(Irf8, Spi1, and Myb) were found to be critical regulators of the
sustained inflammatory responses by 1918 PB2. Thus, we hy-
pothesized that expression of 1918 PB2 could promote in-
creased infiltration and activation of immune cells in the lung.
Indeed, 1918 PB2/avian-infected lungs had a greater represen-
tation of genes involved in the recruitment, infiltration, and
quantity of immune cells than that observed in 1918-like avian
Role of PB2 in Pathogenicity of IAV
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and 1918 HA/avian infected lungs (activation z-score  2) on
day 1 p.i. (Fig. 3C).
To dissect the dynamics of the immune cell infiltration associ-
ated with 1918 PB2 expression, we used an integrative statistical
approach that identifies genes overexpressed in distinct immune
cells allowing us to infer specific cellular infiltration into the lung
(35, 44, 45). Using this approach, we captured an enrichment of
macrophage (Fig. 4A, left) and granulocyte-specific (Fig. 4A,
right) genes in all infection conditions throughout the course of
infection. There was unique enrichment of NK and T cells in the
lung of mice infected with 1918 PB2 expressing viruses (Fig. 4A,
right). To better understand the contribution of these predicted
cell types toward 1918 pathogenesis, we used a second algorithm
for immune cell deconvolution, a digital cell quantifier (DCQ).
The DCQ is a previously validated algorithm that leverages cell
type-specific whole-genome transcriptional expression profiles
derived from 207 immune cells (Immgen; reviewed in reference
46) to infer changes in immune cell quantities based on cell-spe-
cific surface markers (39). We used the DCQ to derive the relative
quantity of predicted cells within the infected lung and infer their
activation states. Specifically, we focused on the immune subsets
inferred through both of our enrichment approaches. Like our
previous analysis, the DCQ revealed a general increase in granu-
locytes, dendritic cells, and monocytes/macrophages throughout
the course of all infections (data not shown). However, we were
able to capture a distinct recruitment of classical Ly6C	 inflam-
matory monocytes (MO.6C	II- and MO.6C	II-.BL) (Fig. 4B),
as well as enhancement of different macrophage subsets infil-
FIG 2 Global analysis of the transcriptional profile of 1918 and 1918-like avian virus infected lungs. (A) Multidimensional scaling (MDS) representation
of the similarities in the lung transcriptional profiles elicited by viral infection over time. Each biological replicate is represented as a single point, where
color denotes virus infection and shape denotes day postinfection. The quality of the representation is provided by the Kruskal stress value, with a low
percentage of Kruskal stress (15.02%) suggesting a faithful two-dimensional representation of global transcriptional differences between viral strains. (B)
Number of highly differentially expressed (DE) genes following virus infection relative to time-matched mocks. Differential gene expression cutoff was
set to |log2 FC|3 and a q-value 0.05 calculated using a moderated t test with subsequent Benjamini-Hochberg correction. (C) Hierarchical clustering
of the union (4,013 genes) of DE genes based on Euclidean distance reveals distinct modules of gene expression in influenza-infected lungs. A heat map
represents the average expression intensities for each infectious condition and time point relative to the average of time-matched mock-infected samples.
(D to F) Time- and strain-dependent distribution of DE genes following infections with influenza viruses. Venn diagrams show the overlap of DE genes
at day 1 (D), day 2 (E), and day 4 (F) postinfection.
Forero et al.
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trating the lung (Fig. 4C) by 1918 PB2 expressing viruses. In
particular, we observed a specific increase in activated macro-
phages (MF.11.cloSER.Salm3.SI and MF.103-11	.Salm3.SI)
that corresponded with the enhanced morbidity of the 1918
PB2/avian virus.
Next, we examined the effect of 1918 PB2 expression in T cell
and NK cell dynamics. Although no notable changes in T helper
cells were captured throughout the course of infection (data not
shown), we were able to unveil a robust activation of CD8	 T cell
responses, which had not been captured initially through our en-
richment analysis of either 1918-like avian or 1918 HA/avian-
infected cells (Fig. 4A, right). Examination of NK cell-specific dy-
namics demonstrated that 1918 PB2 expression impacts both cell
quantity and the distinct activation state throughout the course of
infection. Specifically, 1918 PB2 expression was associated with a
greater representation of host genes which overlapped with those
observed in virus-stimulated NK cells (NK.MCMV7.SP) (Fig.
4D). Severe lung pathology caused by the 1918 virus has been
largely attributed to increased immune cell infiltrate in the lung
(47), which accompanies protracted inflammatory responses.
Our results suggest that 1918 PB2 exacerbates pulmonary inflam-
mation and tissue damage by promoting both the recruitment and
activation of inflammatory monocytes, macrophages, and acti-
vated NK cells (48, 49).
TABLE 1 Canonical pathways affected by 1918, 1918-like avian, and reassortant viruses
Canonical pathway P Ratio
Cluster 1 “orange” (905 transcripts)
Communication between innate and adaptive immune cells 1.60E–12 18/64
Allograft rejection signaling 3.78E–11 14/42
Cross talk between dendritic cells and natural killer cells 6.61E–10 16/69
Autoimmune thyroid disease signaling 2.27E–09 11/31
GVHD signaling 1.30E–07 10/35
Cluster 2 “sky blue” (675 transcripts)
Glycolysis I 1.82E–04 5/23
Hepatic fibrosis/hepatic stellate cell activation 1.91E–04 14/189
Intrinsic prothrombin activation pathway 4.03E–04 5/27
TR/RXR activation 1.31E–02 6/81
Sucrose degradation V (mammalian) 1.46E–02 2/8
Cluster 3 “darkblue” (167 transcripts)
Cell cycle: G2/M DNA damage checkpoint regulation 2.47E–12 10/49
Mitotic roles of Polo-like kinase 6.90E–10 9/61
ATM signaling 2.75E–07 7/59
DNA damage-induced 14-3-3
 signaling 2.32E–07 5/19
GADD45 signaling 1.06E–05 4/19
Cluster 4 “black” (353 transcripts)
Granulocyte adhesion and diapedesis 9.21E–13 18/151
Interferon signaling 6.53E–11 9/29
Role of PRRs in recognition of bacteria and viruses 2.84E–10 14/116
Agranulocyte adhesion and diapedesis 2.54E–09 15/161
Dendritic cell maturation 6.58E–09 14/147
Cluster 5 “dark red” (103 transcripts)
LXR/RXR activation 6.94E–05 5/108
Role of PRRs in recognition of bacteria and viruses 1.17E–03 4/116
IL-10 signaling 2.20E–03 3/65
Role of hypercytokinemia/chemokinemia in the pathogenesis of influenza 5.12E–03 2/27
Role of RIG-I-like receptors in antiviral innate immunity 6.30E–03 2/30
Cluster 6 “yellow” (583 transcripts)
Calcium-induced T lymphocyte apoptosis 1.64E–03 6/54
B cell development 1.88E–03 4/23
Nur77 signaling in T lymphocytes 4.81E–03 5/47
Tight-junction signaling 4.89E–03 10/161
Autoimmune thyroid disease signaling 5.77E–03 4/31
Cluster 7 “red” (1,230 transcripts)
Retinol biosynthesis 2.87E–04 7/29
Tryptophan degradation X (mammalian, via tryptamine) 6.05E–04 5/16
Axonal guidance signaling 6.39E–04 35/421
Glutathione-mediated detoxification 8.13E–04 6/25
Ethanol degradation IV 1.10E–03 5/18
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Loss of Wnt signaling in the lung results in increased viral
pathogenesis. Having characterized the inflammatory responses
enhanced by 1918 PB2, we next explored specific biological pro-
cesses inhibited by viral infection. Overall, we observed an in-
crease in the repression of genes associated with adaptive immune
responses (predominantly major histocompatibility complex
class II genes), epithelial barrier integrity (cluster 6), and lung
metabolic processes (cluster 7) in infected lungs (Fig. 2C and Ta-
ble 1). To identify specific regulators inhibiting these cellular pro-
cesses, we utilized ChEA (38) and ranked the predicted transcrip-
tion factors (TFs) controlling the expression of the union of
downregulated transcripts. Among the top-ranked TFs, we iden-
tified regulators that are crucial for the maintenance of lung ho-
meostasis (Wt1) (50), inflammation-promoted epithelial regen-
eration (Yap1) (51), members of the polycomb repressive
complex (PRC2) (Suz12 and Ezh2) (52), and PRC2 regulatory
proteins (Jarid2 and Mtf2) (53, 54) (Fig. 5A). Additionally, we
identified the LEF/TCF member, Tcf3, which in concert with
-catenin regulates the expression of theWnt/-catenin signaling
pathway effector genes (Fig. 5A). Given that several of the en-
riched TFs regulate Wnt gene expression and downstream Wnt
effector functions (55–57), we hypothesized that expression of
1918 PB2 leads to dysregulation of Wnt signaling pathways.
We first evaluated the relationship between Wnt ligands and
the ChEA-identified transcriptional regulators by constructing a
regulatory network using Ingenuity PathwayAnalysis (IPA).Most
of the top-ranking TFs were found to be directly linked toWnt or
indirectly through Wnt-associated TFs within the network (Fig.
5B). We then examined the impact of 1918 PB2 expression on the
activation state of these transcriptional regulators, taking into ac-
count the global changes in gene expression and their directional-
ity. Expression of 1918 PB2 led to loss of Tcf3 activity, as observed
in 1918 PB2/avian day 1 p.i. profiles. Similar inferences weremade
based on day 4 p.i. 1918WT-infected lung transcriptional profiles,
but not from profiles expressing the avian PB2 homologue (data
not shown).
FIG 3 1918 PB2 promotes proinflammatory responses associated with increased lymphocyte infiltration into the lung. (A) Meta-analysis of early lung tran-
scriptional responses followingH1N1 virus infection. A heatmap represents the relative expression of 57 geneswithin the “black” gene cluster (cluster 4) (derived
from Fig. 2C) that display increased expression when 1918 PB2 is expressed in infected lungs at day 1 p.i. Viruses expressing the 1918 PB2 gene are located on the
left side of the heatmap.Viruseswhich contain PB2 segments that differ from1918PB2 are clustered in the right side of the heatmap. Statistical significance cutoff
was set to a P value of 0.05 as was determined by one-tailed t test. (B) Transcription factors associated with the regulation of gene expression of transcripts
associated with the “black” gene cluster (cluster 4). Regulators were identified using ChIP-X enrichment analysis (ChEA). Bar graphs represent the combined
scores for each regulator (bar length) and the number of target genes associated with each regulator. The PubMed Identifier (PMID) for the specific gene sets
associated with each transcriptional regulator is shown. (C) Gene set enrichment of biological functions pertaining to immune cell regulation derived from IPA.
A bubble plot representation of significant enrichment scores (activation z-score 2) in at least one infectious condition at day 1 p.i. is shown. Crosses signify
a lack of significant enrichment. Bubble diameter represents thelog10 P value as determined by Fisher exact test.
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Expression of 1918 PB2 resulted in the downregulation of tran-
scripts associated with both canonical (Wnt/-catenin) and non-
canonical (Wnt/PCP) Wnt signaling (Fig. 5C). Significant Wnt-
associated pathway enrichment was evident within the first 48 h
after infection with viruses expressing the 1918 PB2 gene (1918
WT and 1918 PB2/avian) and to a lesser extent in the 1918-like
avian virus-infected lungs during late acute infection. Not only
did the expression of 1918 PB2 result in the differential expres-
sion of an increased number of genes encoding Wnt ligands
(Wnt2, Wnt3A, and Wnt10), receptors (Lrp4/6 and Fzd2), in-
hibitors (Sox9), and adaptor molecules, but 1918 PB2 also af-
fected the magnitude of gene expression during the course of
infection compared to 1918-like avian and 1918 HA/avian in-
fection (Fig. 5D).
To determine whether expression of PB2, in the absence of
viral infection, is sufficient to perturb theWnt/-catenin signaling
cascade, we examined the effect of PB2 expression on the tran-
scriptional activation of a -catenin responsive promoter (40). In
human lung epithelial cells, transient expression of either the 1918
PB2 or the 1918-like avian PB2 gene resulted in a significant inhi-
bition of luciferase activity relative to that observed upon expres-
sion of yellow fluorescent protein (YFP) in the presence ofWnt3A
stimulation. The inhibition of -catenin activity was comparable
between both the 1918 and the 1918-like PB2 expressing cells at
both 12 and 24 h poststimulation (Fig. 6A). We further evaluated
the inhibitory effect of PB2 by examining the endogenous mRNA
levels of known Wnt-targeted genes, TROY/TNFRSF19, Axin2,
Nkd1, and Lef1 in Wnt3A-stimulated cells (Fig. 6B). Consistent
with our previous observation, PB2 expression led to marked de-
creases in transcript levels within 12 h of cytokine stimulation
(Fig. 6B, left), which were still noticeable at 24 h poststimulation
(Fig. 6B, right). Therewere significant differences in the inhibition
of TROY, Axin2, andNKD1 gene expression between the two PB2
proteins at 12 h poststimulation, with 1918 PB2 eliciting a more
robust significant inhibition. The integrity of the lung epithelium
is essential for normal lung function andWnt/-catenin signaling
plays an important role in lung development and repair following
injury (58). Thus, by directly repressing the canonicalWnt signal-
ing cascade, 1918 PB2 abrogates the signaling pathways that coor-
dinate lung repair.
Network analysis identifies the relationship between inflam-
matory and epithelial repair responses disrupted by 1918 PB2.
To put the relationships between the biological processes affected
by 1918 PB2 into perspective, we used an integrative network ap-
proach that evaluated the connections between the coexpressed
genes derived from day 1 p.i. 1918 PB2/avian-infected lung tran-
scriptional profiles. The top-scored network generated from the
molecular network analysis was enriched with genes involved pri-
marily in cell-to-cell signaling interaction, inflammatory re-
sponses, and infectious disease as expected from our previous ob-
servations (Fig. 3). Within the manually curated subnetworks, we
identified a network associated with cellular development,
FIG 4 1918 PB2 promotes the recruitment of distinct monocytes, macro-
phages, and activated NK cells, contributing to pulmonary inflammation. (A)
Computational deconvolution of immune cell subsets using GeneAtlas
v3. Represented in the radar plot are the log10 (P value) enrichment scores
for DE genes corresponding to distinct cell subsets as determined by Fisher
exact test. The threshold of significant enrichment was set at 1.3 log10 P
value. (B to D) Immune cell dynamics in infected lungs as predicted by digital
cell quantifier (DCQ). Bar graphs show the relative cell quantities for mono-
cytes (B), macrophages (C), and NK cells (D) after influenza virus infection at
the indicated time points. Distinct colors have been assigned to each immune
cell type from the Immgen compendium. Each cell type name is followed by
the tissue from which it was previously isolated, abbreviated as follows: BL,
blood; BM, bonemarrow; LN, lymph nodes; SI, small intestine; PC, peritoneal
cavity; SLN, subcutaneous LN; and SP, spleen.
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growth, and proliferation in which Wnt3A was among the highly
connected nodes (hubs) (Fig. 7A). Hubs exert regulatory influ-
ence within the network by controlling information flow be-
tween different regions of the network. Interestingly, we also
identified Jnk as a hub, associating the Wnt signaling with lung
inflammatory responses and immune cell infiltration into the
lung (Fig. 7A).
1918 PB2 enhanced both the upregulation of genes highly con-
nected to Jak2, an adaptor molecule of IL-6 family cytokine sig-
naling, as well as the downregulation of genes downstream of
Wnt3a (Fig. 7B). Given that in vitro studies have shown that ca-
nonical Wnt signaling inhibits IAV replication and controls IAV-
induced inflammatory responses (59), our data suggest that in the
context of an in vivo infection, the PB2 gene also inhibits the acti-
vation of the Wnt/-catenin signaling pathway. The enhanced
viral replication and detrimental inflammatory responses pro-
moted by 1918 PB2, coupled with the loss of the regeneration and
repair functions coordinated by Wnt, drive pathogenic IAV dis-
ease (Fig. 7C).
DISCUSSION
Viral virulence determinants, and their adaptive changes, pro-
moting protracted inflammatory responses during 1918 influenza
virus infection is an area of ongoing investigation. In this study, we
examined host transcriptional profiles induced by a 1918-like
avian virus sharing high homology to the pandemic 1918 virus
and reassortant viruses carrying either the 1918 PB2 or HA genes
to better understand the contribution of these host-adaptive genes
to pathogenesis of the 1918 virus. Our results indicate that al-
though the 1918HA and PB2 genes both enhanced the replication
of the 1918-like avian virus, only 1918 PB2 impacted viral viru-
lence. Expression of 1918 HA had less impact on the morbidity
caused by a 1918-like avian virus. This is in contrast to results
obtained in reassortant studies that used a contemporary human
FIG 5 Downregulation ofWnt signaling-associated genes contributes to viral pathogenesis. Functional analysis of downregulated genes following viral infection
demonstrates the inhibition of Wnt signaling genes. (A) Ranking of the top transcriptional regulators of downregulated genes in the infected lung during the
course of infection. Regulators were identified using ChEA. Bar graphs represent the combined scores for each regulator (bar length) and the number of target
genes associated with each regulator. The PMID for the specific gene sets associated with each transcriptional regulator is shown. (B) IPA-generated regulatory
network analysis of the top-ranked TFs. Each node represents a transcription factor or regulatory cytokine. Arrows indicate the relationship between TFs. Color
indicates the predicted (blue) or observed (green) inhibition of molecule activity. (C) Canonical pathways associated withWnt genes. Pathway enrichment was
reported as (log10P value). Bubbles represent significant pathway enrichment, as determined by Fisher exact test. (D)Heatmap of expression intensities ofWnt
signaling-associated genes.
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H1N1 virus (A/Kawasaki/173/2001; K173) as a backbone. 1918
HA enhanced the replication of K173 in murine lungs and caused
increased morbidity (MLD50  4.8 log10 PFU) compared to the
parental virus (MLD50  6.5 log10 PFU) (17). One key differ-
ence is that the present study examines the contribution of HA and
PB2 in the background of a virus with increased viral replication ca-
pacity and that is more pathogenic (1918-like avian; MLD50  5.5
log10 PFU) than either K173 or DK/ALB in mice. In the context of
an intermediately pathogenic 1918-like avian virus, the effect of
mammalian adaptation through lysine substitution of the 627
glutamic acid residue of PB2 is necessary and sufficient to promote
virulence in mice. Although 1918 HA alone did not impact the
1918-like avian virus virulence in mice, it has been demonstrated
that both the 1918-derived HA and PB2 act synergistically to reg-
ulate the transmissibility of the 1918 virus (9, 60). Despite having
a replicative efficiency that was comparable to the 1918 virus, the
1918 PB2/avian virus displayed increased virulence in mice over
the 1918WT virus. It is likely that the enhanced lethality observed
in 1918 PB2/avian-infected mice is attributed not only to in-
creased viral replication (Fig. 1C) but also to the potential inter-
actions between the 1918 PB2 polymerase subunit and the viral
proteins encoded by the 1918-like avian virus (61), as well as spe-
cific viral and host protein interactions that are also necessary
drivers of viral pathogenesis (62). Genome-wide transcriptional
analyses provide an unbiased view of the regulatory processes that
are perturbed during the course of viral infection. Global tran-
scriptional profiling of infected lungs demonstrated that infection
with a virus possessing 1918 PB2 led to increased dysregulation of
host responses to viral infection. Concomitant with pathogenic
1918 PB2-expressing viruses was the elevated expression of genes
involved in inflammatory responses that was consistent with the
recruitment of leukocytes and lymphocytes into the infected lung
(Fig. 3). Previously, we showed that unabated antiviral and in-
flammatory responses associated with the recruitment of proin-
flammatorymonocytes andmacrophages results in increased viral
virulence (35). Here, we show that in addition to the recruitment
of granulocytes and agranulocytes into the lung, 1918 PB2 pro-
motes the infiltration and activation of NK cells following infec-
tion. Although NK cells are crucial mediators of the antiviral re-
sponses to influenza virus infection, their excessive activation
contributes to lung inflammation and tissue damage (48).
Disruption of lung function, airway epithelial integrity, and
airway remodeling has been associated with influenza virus dis-
ease severity. Our gene network analysis revealed that the function
of the 1918 PB2 gene as a virulence factor is associated with inhi-
bition of canonical and noncanonical Wnt signaling pathways.
We observed a greater repression of Wnt genes involved in the
maintenance of lung homeostasis and repair in lungs infectedwith
the 1918WT virus or the 1918 PB2 reassortant virus than in lungs
infected with the 1918-like avian virus. In the presence of 1918
PB2, therewas decreased expression ofWnt,Notch, and Shh genes
encoding developmental regulators that have been implicated in
lung disease. Decreased Wnt/-catenin signaling and Notch sig-
naling are hallmarks of chronic obstructive pulmonary disease
(63). Furthermore,Wnt/-catenin activation ameliorates emphy-
sema in an experimental murine model (64). While the exact
mechanism by which these developmental factors contribute to
the regeneration of the adult lung are not clearly understood, it has
been proposed that Wnt pathways are important for the regula-
tion of lung epithelial progenitor cell maintenance. Additionally,
active repression of canonical and noncanonical Wnt signaling in
the infected lung results in the loss of negative regulation of IL-6-
mediated regenerative inflammatory responses (65), thereby
enhancing tissue damage (51). Furthermore, evidence supports
an important role for Wnt in shaping noxious inflammatory
responses (66). Thus, by both promoting increased cellular
infiltration and downregulating Wnt inhibitory signals, 1918
PB2 contributes to the unabated inflammatory responses that
are associated with severe IAV disease.
Previous studies using primary epithelial cells and cell lines
have shown that Wnt receptor signaling modulates antiviral re-
sponses to influenza virus infection (59, 67). These studies dem-
onstrated direct interactions between the IAV polymerase and
matrix proteins and various proteins in theWnt signaling network
FIG6 The PB2 gene inhibitsWnt-mediated signal transduction. Expression of 1918 PB2 or the1918-like avian PB2 gene results in the inhibition ofWnt signaling
in vitro. (A) Inhibition of -catenin promoter activation in A549 cells. A549-BAR reporter cells were transfected with 4 g of 1918 PB2, avian PB2, or YFP
expression constructs. Cells were stimulated withWnt3A (50 ng/ml) or vehicle control 48 h posttransfection. Firefly luciferase and renilla luciferase activity was
measured at the indicated time points. Firefly luciferase activity was normalized to the renilla luciferase activity. Bar graphs represent the change in firefly
luciferase activity relative to time-matched, vehicle-treated cells. Asterisks indicate statistical significance: ***, P  0.001; **, P  0.01; and *, P  0.05). (B)
Regulation of endogenous Wnt-mediated gene expression by PB2 genes. A549-BAR cells were transiently transfected with a 1918 PB2, avian PB2, or YFP
expression construct as previously indicated. At 24 h posttransfection, fresh culturemediumwas added to cells, whichwere incubated for an additional 24 h prior
to stimulation withWnt3A (50 ng/ml) or vehicle control. Total RNAwas harvested at the indicated time points and the expression of target genes was quantified
by quantitative PCR. Bar graphs represent the fold change in gene expression normalized to GAPDH and time-matched, vehicle-treated cells. Asterisks indicate
statistical significance: ***, P 0.001; **, P 0.01; and *, P 0.05.
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FIG 7 Network analysis of the host responses affected by 1918 PB2 after IAV infection. Identification of disease and biological functions associatedwithWnt signaling.
(A)Molecular network analysis was performed using IPA. Networks were limited to 70 focusmolecules.Within these networks, we identified a network containing 37
focusgenes that ispresentedasagraph indicating themolecular relationshipsbetween inflammatoryandWnt-associatedgenes.Genesandgeneproducts are represented
as nodes (circles), and the biological relationship between two nodes is represented by edges (lines). Node color (pink or blue) indicates up- or downregulation,
respectively. Uncolored nodes represent genes that are relevant to the network but were not identified as DEwithin the data set. Labels indicate gene set overlay and the
most enriched biological functions associated with the identified network. (B)Heatmap of gene product expression intensities of nodes contained within the network.
The results represent the average log2-fold change in expression throughout the course of infectionwith 1918WT, 1918-like/avian, 1918 PB2/avian, and 1918HA/avian
viruses. (C) Schematic of proposedmodel of 1918 PB2 dysregulation of inflammatory responses andWnt-mediated signaling leading to viral pathogenesis.
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(59), potentially leading to the loss of downstream effector func-
tions. Also, PB2 has been previously implicated in the negative
regulation of MAVS-mediated antiviral responses (68–70). Thus,
the direct repression of Wnt/-catenin signaling by PB2 serves as
an additional strategy for immune evasion. However, the rele-
vance of these observations in the context of an in vivo infection
had yet to be addressed. Through a combination of viral genetics
and host transcriptional profiling, we provide amultidimensional
view on the molecular mechanisms involved in the response to
influenza virus infection and show the relationship between 1918
PB2 and the balanced inflammatory/Wnt signaling pathways in
vivo that when perturbed during influenza virus infection lead to
increased morbidity and immunopathogenesis.
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